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Abstract 
BACKGROUND: Nasopharyngeal Angiofibroma is a rare neoplasm in the sphenopalatine foramen. This tumour 
is histologically benign, but clinically malignant because it can erode the bone and surrounding structures, such as 
the pterygopalatine fossa, paranasal sinuses, and nasal cavity. It is a highly vascular tumour, sometimes from 
multiple Feeding arteries, and tends to bleed easily.  
CASE PRESENTATION: In these cases, series, we reported four cases of nasopharyngeal angiofibroma in 
children and one case in an elderly patient. The diagnosis was made by history taking, physical examination and 
Cerebral MSCT Angiography, as well as Digital Subtraction Angiography (DSA). After identification of the Feeding 
artery, we performed transarterial embolisation using polyvinyl alcohol (PVA) foam particles. 
CONCLUSION: Preoperative embolisation in the highly vascular tumour, such as nasopharyngeal angiofibroma, 
is very useful to reduce peri-operative complication of surgery. This procedure can reduce blood loss during 
resection of the tumour and gives better outcomes. 
 
 
 
 
 
 
 
 
Introduction 
 
Nasopharyngeal Angiofibroma (NA) is a rare, 
benign and highly vascular tumour originating in the 
sphenopalatine foramen, and may extend to the 
pterygopalatine fossa, paranasal sinuses and nasal 
cavity [1]. They accounted for 0.05% of all head and 
neck tumours and reported to be 1 per 5,000-60,000 
Ear Nose Throat (ENT) patients in the United States. 
NA occurs exclusively in men. NA generally occurs in 
the second decade of life between 7-19 years old and 
rarely occurs at the age of more than 25 years. 
Randowski et al., classified Nasopharyngeal 
Angiofibroma into three stages, based on the 
expansion of the tumour (Table1) [2], [3], [4]. 
Table 1: Staging systems in juvenile nasopharyngeal 
angiofibromas based on Randowski et al. [5] 
Stage Description of stage 
IA Limited to the nasal cavity and / or nasopharyngeal area 
IB Same as stage I with expansion to one or more paranasal sinuses 
IIA Minimal expansion to the sphenopalatine foramen includes a minimal portion of 
the medial part of the pterygopalatine fossa 
IIB The tumour occupies the entire sphenopalatine fossa space, forces the posterior 
wall of the maxilla forward, shifts laterally or anteriorly from the maxillary artery 
branch, superior expansion may be present, orbital bone erosion 
IIC Extension to the pterygopalatine fissure towards the cheek and infratemporal 
fossa or towards the posterior pterygoid plate 
IIIA Erosion of the skull base (cranial base) with minimal expansion towards the 
intracranial 
IIIB Erosion of the skull base (cranial base) with extensive expansion in the 
intracranial direction with or without involving the cavernous sinus 
 
In this article, we reported our first five 
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institutional cases of nasopharyngeal angiofibroma 
referred from the ENT department, which is four cases 
in children and a rare case in an elderly patient. The 
diagnoses were made by history taking, physical 
examination and radiological imaging with Cerebral 
and carotid Multiple Slice Computed Tomography 
(MSCT) angiography. All patients underwent pre-
operative Digital Subtraction Angiography (DSA) to 
determine the arterial Feeding of the tumour, followed 
by endovascular embolisation using polyvinyl alcohol 
(PVA) foam particles. Clinical manifestations including 
the symptoms and signs of each case will be 
discussed individually, along with the description of 
pre and post-procedural outcome.  
 
 
Case Series 
 
Case 1 
A 13-year-old boy presented with nasal 
obstruction and breathing difficulties experienced for 1 
year earlier, occurring slowly and then worsening in 
the last 3 months. He also had epistaxis in his right 
nasal cavity and felt pain in his right ear. Physical 
examination revealed a lump in the right nasal cavity. 
Physical examination revealed a lump in the right 
nasal cavity. The result of laboratory tests, 
Hemoglobin (Hb) at admission was 10.5 g/dl, and 
postoperative Hb was 10.3 g/dl. MSCT Angiography 
of cerebral and carotid showed an isodense mass 
(30.47 HU) with intense contrast uptake. The mass 
was well-defined, with irregular edges covering the 
nasopharynx particularly at the right sphenopalatine 
foramen extending to the right nasal cavity, right 
maxillary sinus, sphenoid sinus bilateral and right 
ethmoidal, caused bowing of right maxillary and 
ethmoidal bones. It also pushed the nasal septum to 
the left. This patient was diagnosed with stage II right 
nasopharyngeal angiofibroma.  
Cerebral DSA procedure was performed, and 
the catheter tip was navigated to the right common 
carotid artery (RCCA). RCCA injection revealed the 
Feeding artery, which was originated from the C4 
segment of the right internal carotid artery (RICA) and 
the right internal maxillary artery, a branch of the right 
external carotid artery (RECA). Tumour embolisation 
was carried out using 300-500 microns polyvinyl 
alcohol (PVA) foam particles, at the right internal 
maxillary artery, until the tumour blush decreased. 
Feeding artery originating from the right internal 
carotid artery could not be embolized for they were 
small and could not be reached by the available 
microcatheter. The post-surgical diagnosis was 
nasopharyngeal angiofibroma. The amount of blood 
loss during surgery was ± 500 cc. The patient was 
discharged without complication on day 6 after the 
operation. 
Case 2 
A 16-year-old boy presented with left nasal 
obstruction in the past 4 months before admission, 
accompanied by epistaxis. His physical examination 
revealed a tumour, covering his left nasal cavity. The 
result of laboratory tests was as followed: Hb at 
admission was 11.8 g/dl, and Hb post-surgery was 7.8 
g/dl. The result of MSCT Angiography of cerebral and 
carotid showed a centrifuging mass in the 
sphenopalatine canal area with a crowded vascular 
pattern that expanded and widened into the left 
maxillary sinus. The mass encroached the 
pterygomaxillary fossa and filled up most of the 
infratemporal space area. It extended into sphenoid 
and ethmoid sinuses as well as to the left side of the 
nasal cavity which narrowed the airway. No 
intracranial lesions were seen. The main Feeding 
artery was from the branch of the left internal maxillary 
artery. He was diagnosed with Juvenile 
Nasopharyngeal Angiofibroma (JNA) with Feeding 
artery from an internal maxillary artery (Radkowsky 
Grade IIc) (Table 1). 
Cerebral DSA procedure through the left 
external carotid artery (LECA) injection showed a 
tumour blush that supplied by the left internal 
maxillary artery. Tumour embolisation was carried out 
using PVA foam particles 300-500 microns in the left 
internal maxillary artery until the tumour blush on the 
left side disappeared. Tumour resection was 
performed afterwards. The histopathological result 
showed proliferation of blood vessels containing 
erythrocytes, between connective tissue. This finding 
was well-matched with angiofibroma (Figure 1). The 
patient was discharged 6 days after surgery without 
severe complications. 
 
Figure 1: Histological features of angiofibroma. A) Visible 
erythrocyte between the proliferation of connective tissue (black 
arrow) 4 X magnification; B) Thin-walled vascular structure 
containing erythrocytes with a large layer of endothelium and 
fibrous component (blue arrow) 10 X magnification; C) Proliferation 
of connective tissue with components of fibroblast cells, with the 
thin layer of endothelium, 40 X enlargement (staining of 
hematoxylin-eosin) 
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Case 3 
A 16-year-old boy presented with epistaxis for 
4 months before admission. The epistaxis gradually 
worsened during the last 2 months before admission. 
The complaint was accompanied by nasal congestion 
and headache. Physical examination revealed a tumor 
in the right nasal cavity. The result of Hb tests was 
11.2 g/dl and 10.5 g/dl for preoperative and 
postoperative, respectively. The result of MSCT 
angiography of cerebral and carotid showed a 
heterogeneous mass that enhances avidly upon 
contrast administration (90 HU). The mass showed 
well-definite boundaries and regular edges which 
originated from the right side of the nasopharynx and 
compressed the airway. It did not destroy the 
surrounding bones nor infiltrate the intracranial 
tissues. The Feeding artery was the right internal 
maxillary artery. The nasopharyngeal mass was 
consistent with angiofibroma. Cerebral DSA 
procedure was performed, and injection through 
RECA showed tumour blush which was supplied by 
the right internal maxillary artery. The tumour was 
embolized using PVA particles 300-500 microns in the 
right internal maxillary artery until the tumour blush on 
the right side disappeared. Subsequently, resection 
surgery was performed with a total of ± 500 cc blood 
loss during the procedure. The tissue was sent to the 
histopathological laboratory, and the result was 
consistent with angiofibroma. The patient was treated 
for 5 days postoperatively and eventually got 
discharged.  
 
Case 4 
An 11-year-old boy visited the ENT outpatient 
clinic with his parents. The boy came with right nasal 
obstruction for 3 months before admission. Physical 
examination showed proptosis of the right eye and a 
tumour in the right nasal cavity (Figure 2). Laboratory 
examination showed Hb results were 14.4 gr/dl and 
14.5 g/dl for preoperative and postoperative, 
respectively.  
 
Figure 2: A) Proptosis of the right eye; B) Tumor is visible through 
right cavum nasi 
 
Noncontrast CT scan on paranasal sinuses 
showed expansive mass with heterogeneous density, 
well-defined boundary, and irregular edge. The size of 
the mass was 4.86 x 4.34 x 4.84 cm and tended to 
originate from the right maxillary sinus. The tumour 
infiltrated the right nasal cavity, sphenoid sinus, 
ethmoid sinus, right frontal sinus and pressed the 
nasal septum to the left and caused destruction of the 
lateral wall of the right maxillary sinus. The diagnosis 
was right sinonasal mass involving more than one 
paranasal sinuses (Figure 3).  
 
Figure 3: Paranasal Sinus CT Scan without contrast with coronal 
section. A) Tumours in from the right maxillary sinus compressed 
the right ethmoidal sinus and pushed nasal septum to the left. The 
tumour also destroyed the lateral wall of the right maxillary sinus; B) 
The tumour infiltrated the right sphenoid sinus; C) The tumour also 
infiltrated the right frontal sinus; D) Head CT coronal section without 
contrast, the nasal septum was pushed to the left, and the tumour 
infiltrated the ethmoidal sinus and right sphenoid sinus 
 
Cerebral and carotid MSCT angiography 
revealed an isodense mass, with a regular edge, 
about 4.9 x 4.0 x 3.2 cm, originated from the right 
maxillary sinus. The tumour extended into the right 
nasal cavity, right ethmoidal sinus, right sphenoidal 
and right orbital cavity, destroyed the right maxillary 
and right zygomaticus bone. The right lamina 
papyracea of the ethmoidal bone and the nasal bone 
slightly pressed anteriorly (Figure 4). 
 
Figure 4: Cerebral and carotid MSCTA. A) There was an isodense 
mass with well-defined and regular edges; the size about 4.9 x 4.0 x 
3.2 cm, the tumour appeared to originate from the right maxillary 
sinus, pressing the nasal septum to the left; B) The tumor pressed 
the right ethmoidal and sphenoid sinus; C) The tumour destroyed 
the lateral wall of right maxillary sinus and pushed nasal septum to 
the left; D) The tumor pressed right frontal sinus 
3A 3B
3C 3D
4A 4B
4C 4D
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The Feeding artery appeared to originate from 
the right internal maxillary artery (Figure 5). The 
diagnosis was a sinonasal mass corresponding to 
sinonasal angiofibroma. Cerebral DSA procedure via 
RECA showed the presence of a tumour blush that 
was supplied by the right internal maxillary artery 
(Figure 6, A and B).  
 
Figure 5: MSCTA Cerebral and carotid. A) Feeding artery was 
originating from the right internal maxillary artery; B) There was an 
isodense mass with well-defined regular edges; the size is 4.9 x 4.0 
x 3.2 cm, the mass was from the maxillary sinus 
 
 Tumour embolisation was performed using 
PVA particles 300-500 microns through the right 
internal maxillary artery until the tumour blush on the 
right side disappeared (Figure 6, C). After that, a 
nasopharyngeal angiofibroma resection surgery was 
performed with a total of ± 500 cc of blood loss during 
surgery. The tissue was sent to the histopathological 
anatomy laboratory with the results was following 
angiofibroma. The patient was treated for 5 days 
without complications and got discharged. 
 
Figure 6: Digital Subtraction Angiography (DSA) cerebral, injection 
of the right external carotid artery (RECA). A) Pre embolization: 
There was a tumour blush with Feeding artery from the right internal 
maxillary artery (yellow arrow); B) Tumor blush was shown by blue 
arrow; C) Post embolization using PVA particle, in the right internal 
maxillary artery until the tumour blush on the right side was no 
longer visible (red arrow). 
 
 
Case 5 
A 61-years-old man came to the emergency 
department with unprovoked epistaxis for 5 months 
before admission. Laboratory examination showed the 
Hb results were 11.1 gr/dl and 10.5 g/dl for 
preoperative and postoperative, respectively. The 
results of Noncontrast CT scan on paranasal sinuses 
coronal view showed isodense mass (26 HU), with 
relatively firm boundaries, irregular edges, and without 
calcification. The tumour was from the right nasal 
cavity, eroded the right maxillary, extended to the right 
ethmoid sinus and pressed the nasal septum to 
contralateral. This finding was suggestive of right 
nasal cavity mass which extended into the right 
maxillary sinus and the right ethmoid sinus. Cerebral 
and carotid MSCT angiography showed a mass in the 
right nasal cavity, which was hypervascular and 
originated from the right maxillary artery. Cerebral 
DSA procedure was performed through the right 
internal carotid artery (RICA). Tumour blush was 
seen, originated from the right ophthalmic artery 
(Figure 7, A and B). Injection of the RECA also 
showed the feeding artery from the right internal 
maxillary artery (Figure 7, A and B). The tumour was 
embolized using PVA particles 300-500 microns until 
the tumour blush decreased (Figure 7, C and D). The 
feeding artery originated from the right ophthalmic 
artery was not embolized because of the risk of 
causing blindness.  
 
Figure 7: Digital Subtraction Angiography (DSA) Cerebral. A) Right, 
Common Carotid Artery (RCCA) Anterior-Posterior (AP) view pre 
embolisation. Tumour blush was seen (yellow arrow); B) RCCA the 
pre-embolized: lateral view. The Feeding arteries were from the 
right internal maxillary artery and the right ophthalmic artery; C) 
RCCA AP view post embolization, tumour blush was still visible 
(black arrow); D) RCCA lateral view, post embolization, blood 
supply from the right internal maxillary artery did not appear, while 
Feeding artery from the right ophthalmic artery was still visible.  
 
5A 5B
6A 6B 6C
7A 7B
7C 7D
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The tumour blush was still visible but 
decreased to some extent (Figure 7D). After that, a 
nasopharyngeal angiofibroma resection surgery was 
performed with a total of ± 500 cc blood loss 
intraoperative. The tissue was sent to the 
histopathological test, and the result was 
angiofibroma. The patient was treated for 5 days 
without complications before finally discharged. 
 
Pre-operative Endovascular Embolization 
 and the Outcomes 
All patients in this case series were treated 
with pre-operative embolisation before tumour 
resection. Tumour embolisation was performed using 
the endovascular trans-arterial technique, with PVA 
foam particles (William Cook Europe ApS, Denmark) 
as embolic material. The procedure was coded as 
Percutaneous Transcatheter Infusion Embolization 
(ICD-9-CM 99.29).  
Cerebral DSA procedures were performed in 
case 1 and 4 with asepsis preparation and general 
anaesthesia. The right femoral artery was 
catheterised, using a 6F sheath (Merit Medical 
Systems Inc., South Jordan, USA, USA), and a 6F 
JR4 guide catheter (Terumo Corporation, Tokyo, 
Japan). The procedure was followed by tumour 
embolisation, using a 6F JR4 guide catheter (Terumo 
Corporation, Tokyo, Japan), 2.4F microcatheter 
(Terumo Corporation, Tokyo, Japan) and 1.4 micro 
guidewires (Terumo Corporation, Tokyo, Japan).  
 Cerebral DSA procedure was performed in 
case 2 with asepsis preparation and local 
anaesthesia. The right femoral artery was 
catheterised using 6F sheath (Merit Medical Systems 
Inc., South Jordan, Utah, USA), 5F HH1 guide 
catheter (Terumo Corporation, Tokyo, Japan), 6F 
JR3.5 catheter (Terumo Corporation, Tokyo, Japan). 
Subsequent tumour embolisation was done by using a 
6F JR3.5 guide catheter (Terumo Corporation, Tokyo, 
Japan), 2.4F microcatheter (Terumo Corporation, 
Tokyo, Japan), 1.4F micro guidewire (Terumo 
Corporation, Tokyo, Japan) and particulate PVA 
contour 300-500 microns. 
Cerebral DSA procedure in case 3 was 
performed with asepsis preparation and local 
anaesthesia, right femoral artery catheterised with 6F 
sheath (Merit Medical Systems Inc, South Jordan, 
Utah, USA), and 6F JR4 guide catheter (Terumo 
Corporation, Tokyo, Japan).  
Cerebral DSA procedure in case 5 was 
performed with asepsis preparation and local 
anaesthesia, right femoral artery was catheterized 
using 6F sheath (Merit Medical Systems Inc., South 
Jordan, Utah, USA), 6F JR4 guide catheter (Terumo 
Corporation, Tokyo, Japan), and 0.038 guidewire 
(Terumo Corporation, Tokyo, Japan). The procedure 
was followed by tumour embolisation procedure; using 
6F JR4 guide catheter (Merit Medical Systems Inc., 
South Jordan, Utah, USA), 1.8F microcatheter 
(Terumo Corporation, Tokyo, Japan) 1.4F micro 
guidewire (Terumo Corporation, Tokyo, Japan) and 
particulate PVA contour 300-500 microns. 
The result of tumour embolisation in case 2, 3 
and 4 was satisfactory, with the total disappearance of 
tumour blush. In case 1 and case 5, the tumour blush 
is still visible, although reduced to some extent, 
because the tumour was also received blood supply 
from the right internal carotid artery case 1, and the 
right ophthalmic artery case 5 (Table 2). Within 2 to 3 
days of embolisation, the patients underwent tumour 
resection surgery and postoperative treatment for 
approximately 5-6 days. All the patients were 
discharged with good outcome and without any 
complications. 
Table 2: Demographic, laboratory, and radiological 
characteristic of each patient 
Cases Sex Age 
/ yrs 
Pre- 
Op. 
Hb 
(g/dl) 
Post- 
Op. Hb 
(g/dl) 
MSCT Scan of Cerebral and 
Carotid Angiography 
(Arterial Feeding) 
DSA Arterial Feeding 
1 M 13 10.5 10.3 Right Internal maxillary 
artery, a branch of the 
external carotid artery 
C4 segment of the right 
internal carotid artery; 
Right Internal maxillary 
artery, a branch of the 
external carotid artery 
2 M 11 11.8 7.8 Left internal maxillary artery, 
a branch of the external 
carotid artery 
Left internal maxillary 
artery, a branch of the 
external carotid artery 
3 M 16 11.2 10.5 Right Internal maxillary 
artery, a branch of the 
external carotid artery 
Right internal maxillary 
artery, a branch of the 
external carotid artery 
4 M 11 14.4 14.5 Right Internal maxillary 
artery, a branch of the 
external carotid artery 
Right internal maxillary 
artery, a branch of the 
external carotid artery 
5 M 61 11.1 10.5 Right Internal maxillary 
artery, a branch of the 
external carotid artery 
Right internal maxillary 
artery, a branch of the 
external carotid artery 
and Right ophthalmic 
artery 
 
 
 
Discussion 
 
Nasopharyngeal angiofibroma (NA) was first 
described in ancient times by Hippocrates (5
th
 century 
BC). NA is a rare, benign fibrovascular tumour, at the 
superoposterior area of the sphenopalatine foramen 
and is often found in young men, between 14-25 
years old. It is estimated to be 0.05% of all benign 
Head and Neck tumours. These tumours are 
histopathologically benign, yet clinically destructive. 
The most common presenting symptoms are 
unilateral nasal congestion, nasopharyngeal lump and 
recurrent epistaxis. In the later stages, this tumour can 
cause facial deformity, proptosis, headache and 
deafness. Computed tomography (CT-Scan) and 
magnetic resonance imaging (MRI) is the most widely 
used modalities for diagnosis and evaluation of 
tumour growth, bone destruction and staging of 
angiofibroma. Also, a pre-operative angiographic 
procedure is performed to identify Feeding artery and 
to describe tumour size and location [1], [6], [7].
 
In our 
case series, 4 patients were aged between 14-25 and 
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1 patient was 61 years old, thus considered as a rare 
case. All patients are male. Almost all patients 
presented with the chief complaint of nasal 
congestion, difficulty breathing, epistaxis as well as 
mass in the nasal cavity. The diagnosis was 
confirmed by radiological examination in the form of 
cerebral and carotid MSCT angiography and digital 
subtraction angiography (DSA). 
Surgical resection of nasopharyngeal 
angiofibroma is the mainstay of treatment. Other 
treatment modalities include radiation, cryotherapy, 
electrocoagulation, hormonal therapy, embolisation 
and injection of sclerosing agents [8],[9].
 
Although 
surgical excision is the definite treatment, the risk of 
this procedure is high, particularly due to the high risk 
of bleeding, since the tumour is highly vascularized. 
Fonseca et al. reported that there was no significant 
difference in bleeding risk between 15 patients who 
undergo surgery without preoperative embolisation 
and those with pre-operative embolisation [10].
 
Gaillard et al. reported that there could be the risk of 
tumour recurrence in patients who were not pre-
operatively embolized. Furthermore, Gaillard 
confirmed that cure rates could be as high as 94% if 
pre-operative tumour embolisation is performed [11]. 
In our institution, this is the first serial cases of 
preoperative tumour embolisation for nasopharyngeal 
angiofibroma, before tumour resection was performed. 
Embolisation is a minimally invasive procedure, aimed 
at devascularization of tumour or cerebrovascular 
malformation. A catheter is passed through femoral, 
navigated until its tip is in the target vessel. In this 
case, the target vessel is the Feeding artery of the 
nasopharyngeal tumour. An embolisation agent is 
then ejected through the catheter tip into the blood 
vessel to revascularize the tumour.  
In all five cases, the internal maxillary artery, 
a branch of the external carotid artery, is the main 
Feeding artery for the Nasopharyngeal Angiofibroma 
(Table 2), but there are other Feeding arteries, such 
as the C4 segment of the right internal carotid artery 
and the right ophthalmic artery. After the Feeding 
artery was identified, pre-operative tumour 
embolisation was performed using the PVA foam 
particle agent. PVA foam particle is routinely used as 
embolisation agent for preoperative embolisation. 
PVA can produce permanent and non-absorbing 
occlusion, with a low rate of blood vessel 
recanalisation. All five patients experienced anaemia 
both before and after tumour embolisation and tumour 
resection. All patients underwent tumour resection 
after the pre-operative embolisation. During the 
surgical procedure, the blood loss is only around 500 
cc, and all patients were discharged, after 5-6 days of 
postoperative treatment, without any severe 
complications. 
In conclusion, preoperative embolisation of 
the Feeding artery for Nasopharyngeal Angiofibroma 
is a very advisable procedure. Pre-operative 
embolisation can reduce blood loss during peri-
operative surgical operation and improve outcome. In 
our institution, we routinely perform it. Before 
embolisation procedure, thorough evaluation with 
MSCT angiography and DSA must be performed to 
evaluate the Feeding artery. 
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